Table 2.
Serum and whole blood oxidant activity; MDA and MPO levels, and antioxidant activity; CAT and GSH-Px levels in anti-CCP(+) and anti-CCP(-) patients with RA.
| Anti-CCP | N | Mean | Std. Deviation | p value | |
|---|---|---|---|---|---|
| Serum GSHpx (U/ml) | negative | 24 | 0.47 | 0.25 | 0.622 |
| positive | 25 | 0.48 | 0.19 | ||
| Whole Blood GSHpx (U/ml) | negative | 24 | 14.10 | 6.67 | 0.614 |
| positive | 25 | 15.63 | 4.39 | ||
| Serum CAT (k ml−1) | negative | 24 | 0.11 | 0.03 | 0.267 |
| positive | 25 | 0.13 | 0.01 | ||
| Whole Blood CAT (k ml−1) | negative | 24 | 114.23 | 21.15 | 0.322 |
| positive | 25 | 112.21 | 20.66 | ||
| Serum MDA (nmol/ml) | negative | 24 | 3.34 | 0.15 | 0.141 |
| positive | 25 | 3.52 | 0.32 | ||
| Whole Blood MDA (nmol/ml) | negative | 24 | 50.39 | 7.29 | 0.233 |
| positive | 25 | 53.63 | 7.50 | ||
| Serum MPO (U/ml) | negative | 24 | 0.64 | 0,28 | 0.487 |
| positive | 25 | 0.62 | 0,20 | ||
| Whole Blood MPO (U/ml) | negative | 24 | 67.44 | 25.04 | 0.218 |
| positive | 25 | 71.13 | 20.93 |